The classical hematopoietic hierarchy, which is mainly built with fluorescence-activated cell sorting (FACS) technology, proves to be inaccurate in recent studies. Single cell RNA-seq (scRNA-seq) analysis provides a solution to overcome the limit of FACS-based cell type definition system for the dissection of complex cellular hierarchy. However, large-scale scRNA-seq is constrained by the throughput and cost of traditional methods. Here, we developed Microwell-seq, a high-throughput and low-cost scRNA-seq platform using extremely simple devices. Using Microwell-seq, we constructed a single-cell resolution transcriptome atlas of human hematopoietic differentiation hierarchy by profiling more than 50,000 single cells throughout adult human hematopoietic system. We found that adult human hematopoietic stem and progenitor cell (HSPC) compartment is dominated by progenitors primed with lineage specific regulators. Our analysis revealed differentiation pathways for each cell types, through which HSPCs directly progress to lineage biased progenitors before differentiation. We propose a revised adult human hematopoietic hierarchy independent of oligopotent progenitors. Our study also demonstrates the broad applicability of Microwell-seq technology.
Introduction
The classical model of hematopoiesis is a branched tree, rooted from long-term hematopoietic stem cell (LT-HSC) and followed by multipotent, oligopotent and unipotent progenitor stages (Akashi et al., 2000; Doulatov et al., 2012; Kondo et al., 1997; Orkin and Zon, 2008) . However, this model is mainly based on the FACS cell type definition system, which is heavily biased due to the limited choices of surface markers. Several studies using in vivo tracing challenged this classical model and showed the hematopoiesis were actually maintained by large kinds of progenitors which each have strong lineage bias (Busch et al., 2015; Sun et al., 2014) . Single cell qPCR using hundreds of marker genes also demonstrates the strong heterogeneity within the hematopoietic progenitor population (Guo et al., 2013) . Recently, by coupling single cell qPCR assay and single cell differentiation assay, Notta et al. showed that Er-Mk lineages emerges directly from multipotent cells, and proposed a revised human hematopoietic hierarchy (Notta et al., 2016) . However, the selection of cell populations from these studies still depends on classical FACS gating scheme. A systematic single cell atlas of human hematopoietic transcriptome with minimal influence from traditional hierarchy is lacking.
scRNA-seq is a powerful technology for profiling the whole transcriptome of individual cells (Hashimshony et al., 2012; Ramskold et al., 2012; Tang et al., 2009; Treutlein et al., 2014) , which can be used to dissect cellular heterogeneity and construct lineage hierarchy. However, traditional scRNA-seq methods are expensive and time-consuming for large-scale experiments. Thus, recent studies using traditional scRNA-seq to investigate the heterogeneity of human HSPCs are not comprehensive due to their scant cell quantity (Notta et al., 2016; Velten et al., 2017) . Lately, several high-throughput scRNA-seq methods have been developed, including Drop-seq and inDrop (Klein et al., 2015; Macosko et al., 2015) . Nevertheless, Dropseq and inDrop heavily rely on sophisticated microfluidic devices and pump systems, which constrain their extensive application in small labs.
Here, we report Microwell-seq, an extremely simple method utilizing an agrose-made microwell array and barcoded beads to profile thousands of single cells for transcriptome analysis. Microwell-seq demonstrates great advantages in convenience and simplicity, which makes it accessible to every lab.
Using Microwell-seq, we constructed a transcriptomic atlas of human hematopoietic hierarchy by profiling the transcriptome of more than 50,000 single cells, which is by far the most comprehensive atlas of in vivo human HSPC population. The atlas showed that adult human HSPC compartment is dominated by progenitors in a lineage-primed status while the classical oligopotent HSPCs are not observed. Unique transcriptional priming pathways can be reconstructed by combining the differentiated CD34 -cells. In further functional assay experiments, the lineage-primed HSPCs showed strong commitment preference to specific cell type, which validated our finding in the transcriptomic atlas. Thus, we propose a revised adult human hematopoietic hierarchy in which HSPCs directly progress to unipotent progenitors without the oligopotent stage, and the pool of unipotent progenitors will give rise to the various kinds of blood cells.
Results

Microwell-seq is a convenient, low-cost and simple platform for high-throughput scRNA-seq
In Microwell-seq, an agarose microarray is used to trap individual cells; and magnetic beads are used to capture the mRNAs. The diagrams showing the process of bead synthesis and microarray fabrication are shown in Figure 1 . Both procedures are extremely simple. The barcoded beads are synthesized by 3 rounds split-pool ( Figure 1A ). Every oligonucleotide consists of a primer sequence, a cell barcode, a unique molecular identifiers (UMI) and a poly T tail (Fan et al., 2015; Islam et al., 2014; Klein et al., 2015; Macosko et al., 2015) . In the first-round split-pool, magnetic beads coated with carboxyl groups are randomly distributed into a 96-well plate where the 5' amino modified oligonucleotides are conjugated to the beads. The oligonucleotides in each well have a unique barcode sequence. Then the beads are pooled and split into another 96-well plate where the second barcode sequence is introduced by single cycle PCR. In the final-round split-pool, the third barcoded sequence, unique molecular identifier (UMI) (Islam et al., 2014) and PolyT tail are introduced (Table S1 ). After the split-pool, all the oligonucleotides on the same bead will have the same cell barcode and different UMI, while oligonucleotides on different beads will have different cell barcodes. The cell barcodes will be used to demultiplex the pooled sequencing results to individual cells. The UMI will be used to track single molecules to reduce the quantitative bias introduced during amplification. This beads synthesis process is easy to perform for all labs.
The fabrication of microarray is also very simple and cheap ( Figure 1B ). First, a silicon chip with 100,000 microwells on the surface is manufactured and can be used as a permanent mold. Second, a PDMS chip with 100,000 micropillars is made by simply pouring PDMS on the surface of silicon chip.
Finally, an agarose microwell chip is made by pouring agarose to the PDMS chip. The advantage of this method is that both silicon chip and PDMS chip are reusable, which means a single silicon chip can be used to make thousands of agarose microarrays. The size of the agarose chip can be easily adjusted by making different size of PDMS chips for a wide range of input sample size and concentration. It is also time-saving since it only takes minutes to make an agarose chip for each experiment.
Cross-species experiments proves the fidelity of Microwell-seq in capturing single-cell transcriptome
The whole workflow of Microwell-seq is shown in Figure 2A . An agrose plate with tens of thousands of microwells is used for trapping thousands individual cells and beads, similar to the Cytoseq platform (Fan et al., 2015) . After cells are loaded to the wells, we will inspect the microwell array under microscope and pick out rare cell doublets by capillary tube, which takes about several minutes.
Then barcoded magnetic beads are loaded and trapped into each well by size. Every single bead is conjugated with millions of oligonucleotides which share the same cellular barcode ( Figure S1 ). After incubation of beads and cells in a soft flow of lysis buffer, beads with captured mRNA are retrieved by magnet. The procedure from cell loading to the cell lysis can be limited to only 15 minutes, largely preserving the healthiness of the cells. We collect the beads in a 1.5 ml tube where reverse transcription and template switch are performed using Smart-seq2 protocol (Picelli et al., 2013) .
Amplified cDNA will be fragmented by a customized transposase which carries two identical insertion sequences (see online method). The 3' ends of transcripts are then enriched in the following library generation PCR and sequenced using Illumina Hiseq platforms (Table S2) .
To evaluate the cross-contamination rate in Microwell-seq method, we performed mixed species experiment with cultured human (293T) and mouse (3T3) cells. Then we identified the ratio of reads mapped to both human and mouse genome in every single cell ( Figure 2B ). We found that
Microwell-seq produced high-fidelity single-cell libraries with no more than 0.6% cell doublets. 8,000
genes and 50,000 transcripts can be detected on average by saturating sequencing ( Figure 2C ). Low reads versus genes number ratio were observed in large-scale experiments ( Figure 2D ). Cell cycle score were calculated for each human 293T cell based on previously reported phase-specific genes and methods ( Figure 2E ) (Macosko et al., 2015; Whitfield et al., 2002 and various subpopulations were also observed within the two main clusters ( Figure S2A ). Thawed mPB CD34 + cells from batch1 and batch2 were visualized on a t-SNE map. It is worth emphasizing that Microwell-seq work stably even with thawed cells ( Figure S2B ).
A transcriptome atlas of 44,914 human HSPCs at single-cell resolution revealed a revised human hematopoiesis model
By harnessing the power of Microwell-seq, we aimed to systematically profile an atlas of adult human stem and progenitor cells with minimal influence from classical flow-based cell type definition system.
We therefore collected fresh peripheral blood from two Chinese male donors after GCSF mobilization, and then enriched hematopoietic stem and progenitor cells using CD34 + selection kit. FACS analysis showed that 98% of enriched cells were indeed CD34 + ( Figure 3A ). Using Microwell-seq, single cell transcriptomes of 44,914 mPB CD34 + cells from 7 independent library generation experiments were successfully profiled. The data is of high quality and is by far the most comprehensive single cell transcriptome atlas of HSPCs.
Through computational analysis , we identified 20 subpopulations ( Figure 3A) .
Each subpopulation showed a highly specific gene expression pattern ( Figure 3B ). We found that, within the same donor, batch effects from different library generation experiments were minimal, as all 20 clusters were reproducibly seen from all 7 batches of experiments, with slight proportion difference between the two assayed donors ( Figure S2C and S2D). From down sampling experiments,
we found that sample size should reach ten thousand single cells to find major defined subpopulations ( Figure S3 ). 4289 cells were presented on the two-dimension space reduced by SPRING (Weinreb et al., 2017) , depicting the dynamic trajectories of progenitor cells that differentiate from HSPCs ( Figure   3C ).
Heatmap showed the hierarchical clustering of the single cell data sets with clear differential gene expression modules and cell type clusters ( Figure 3D and Table S3 ). Interestingly, many of the defined human myeloid clusters such as the CEBPE + cluster, CD14 + cluster and CD41 + cluster, strongly resemble published mouse myeloid clusters by MARS-seq analysis (Jaitin et al., 2014; Paul et al., 2015) , suggesting that these clusters are conserved among species. The related markers of these clusters are also highlighted in another recent single cell analysis work on human hematopoietic progenitors using a MARS-seq like platform (Velten et al., 2017) (Notta et al., 2016; Paul et al., 2015) . C5/C8 was defined as basophil progenitor by the expression of transcription factors (TFs) GATA2 and LMO4, along with basophilic gene like MS4A2, TPSB2 and RNF130 (Paul et al., 2015) . Markers of erythrocyte progenitors, including GATA1, KLF1, MYC, TFRC(CD71), HBB and HBD, were strongly expressed in C6 and C7, which delineated them as CD34 + erythrocyte progenitors (Novershtern et al., 2011; Paul et al., 2015) . GATA1 and KLF1 play well-established roles in erythroid differentiation (Novershtern et al., 2011) . In addition, C12 showed high HBB and SOX4 expression, indicating its erythroid identity (Paul et al., 2015) . These results provided powerful support for the existence of erythroid progenitors in the CD34 + compartment, consistent with the study of Notta et al. (Notta et al., 2016) .C10 and C19/C20 were defined as eosinophil and neutrophil progenitors: C10 was marked by expression of RNase2 (EDN) and RNase3 (ECP) (Rosenberg et al., 2013) , which suggested an eosinophil fate. They also co-expressed granulocyte genes like CST7 (Paul et al., 2015) . C19 showed early neutrophil characteristics, with extremely high level of CEBPE, along with CSF3R (CD114), CD177, S100A9, S100A8 and S100P (Novershtern et al., 2011; Paul et al., 2015) . C20 showed similar pattern to C19 but with lower gene expression level. C17 exhibited strong levels of known monocyte markers including LYZ, CD14, CSF1R, MS4A7, and monocyte TFs like FCN1 and MNDA (Novershtern et al., 2011; Paul et al., 2015) .
C18 was defined as dendritic cell progenitor by expression of CD74, MHCII-related genes and the TFs STAT1, ID2 and IRF8.C13 was suspected to be epidermal/Langerhans dendritic cell progenitor by the expression of CXCL2, which was closely related to dendritic cell maturation (Lee et al., 2009 ).
ID2, enriched in C14, was very recently regarded as an essential marker of dendritic cell (Paul et al., 2015) . C11 expressed high levels of cell cycle related gene like TK1 and PCNA. C16 uniquely expressed JUN, which should be early T cell characteristic (Novershtern et al., 2011) .
Finally, we found that C15 was different from all the other clusters by lack of any lineage-defining TFs or markers (e.g. MNDA /KLF1/GATA1 or ELAN /CD62L / MPO). These cells did express HSPC markers such as CD34, SPINK2 and SOX4, so we define C15 as the undifferentiated multipotent hematopoietic stem and progenitor type in agreement with Paul et al. study (Paul et al., 2015) .
Based on single cell transcriptome profiling, our analysis suggests that the classically defined oligopotent progenitor types such as common myeloid progenitor (CMP), common lymphoid progenitor (CLP), megakaryocytic/erythroid progenitor (MEP), granulocyte and monocyte progenitor (GMP), common DC precursor (CDP), macrophage/DC progenitor (MDP) and multilymphoid progenitor (MLP) cannot be recognized in the main clusters of adult human hematopoietic stem and progenitor cells (Doulatov et al., 2010; Geissmann et al., 2010; Novershtern et al., 2011; Onai et al., 2007) . On the other hand, we found that the mPB CD34 + cells are dominated by progenitors with expression of lineage specific modules. Interestingly, even in the multipotent cluster C15, we still observe significant heterogeneity, suggesting a more complexity within hematopoietic stem cells ( Figure S4 ). In the adult human hematopoietic hierarchy, unipotent progenitors appear to be directly downstream of multipotent progenitors. The oligopotent intermediate state cannot be found from the transcriptome-based single cell analysis.
Extraction of subcluster structure within the defined progenitor types
Using the comprehensive data set, we then aim to further dissect the subcluster structure within the defined progenitor types. All defined clusters show further heterogeneity, suggesting the complexity of the differentiation pathway ( Figure 4A ). We found the cluster 1 can be further grouped into three subsets, each with specific gene expression pattern. Subset 1 of C1 (C1S1) It worth mentioned that we found three subgroups even in the defined HSPC population. C15S1
appears to correspond to an early erythroid and megakaryocytic progenitors with higher expression of HBB and PPBP. C15S2 is enriched for some unknown gene like DUT, GINS2 and cell cycle related gene including TK1 and PCNA. Finally, C15S3 is not characterized by any lineage specific marker suggesting a more primitive HSPC state. The subcluster structure of different populations appears to correspond to different differentiation stages rather than contaminations and technical noise. Based on the clear cell clusters and gene expression modules, we infer that the human hematopoietic lineage differentiation takes concrete but unidirectional "steps" to move from multipotent stage to mature cell types ( Figure 4B ).
Modeling lineage differentiation pathway in the human hematopoietic system
In order to obtain the reference single cell transcriptomes for major differentiated cell types in the adult human hematopoietic hierarchy we further profiled 4900 CD34 -cells from GCSF mobilized peripheral blood sample. We defined eight main clusters within our CD34 -dataset. After downsampled CD34 + dataset to the same scale as CD34 -dataset, we visualize it on a 2-dimension tSNE map ( Figure   5A ). mPB CD34 + cells and mPB CD34 -cells were separated. The main force driving them apart results from distinct transcriptional expression. mPB CD34 + cells have higher level of CD34 expression, further convincing its identity as progenitor cells ( Figure S5A ). All cells were divided into 28 clusters. P1-P20 is CD34 positive cells that above mentioned C1-C20, including pro-eosinophil, pro-neutrophil, pro-natural killer cells, pro-B cell, pro-megakaryocyte, pro-erythrocyte, pro-NK/T, pro-basophil, pro-dendritic cells and pro-monocytes ( Figure 5B ). Meanwhile, mature cell (CD34 -)
cluster N1-N8 correspond to eosinophil, neutrophil, NK/T cells, B cell, dendritic cells and monocytes ( Figure 5C ). The differential markers within the 8 CD34 -clusters were also found in CD34 + clusters, linking progenitors and mature cells from these two datasets.
N1, highly expressing EDN and ECP and granulocyte marker MPO, is mature eosinophil, corresponding to the P10. N2-N4 defined by neutrophil-specific makers like CEBPE, CD177 and CSF3R (CD114), is relevant to P19-20. Markers of NK cell, including GZMH, GZMA and GZMB, were strongly expressed in N5, which delineated them as mature NK cells. N5 also highly expressed T cell markers such as CD3, CD8, CXCR4 and CD69 (Bagger et al., 2016 ). So we speculated that N5
were NK/T cell, a heterogeneous group of T cells that share properties of both T cell and NK cell (Godfrey et al., 2004) . N5 is related to P2, The NK/T progenitor. B cell markers gene like CD79A, IGKC and MS4A1 are enriched in N6, linking them to P1, the B cell progenitor. N7 was marked by expression of CD74 and MHCII related gene, which suggested a dendritic fate, corresponding to P18.
N9 is closely related to P17, showing monocyte characteristics, with high expression of CD14, along with LYZ and CEBPD (Novershtern et al., 2011; Paul et al., 2015) . Correlation heatmap also indicated a partial similarity between CD34 + clusters and CD34 -clusters ( Figure S5B ). Selecting neutrophil as a candidate, we established pseudotime from neutrophil progenitor cells to mature neutrophil cells ( Figure 5D and 5E) and constructed transcriptional priming pathways in neutrophil cell ( Figure 5F and 5G). Transcription factors such as CEBPE and SPL1 gradually increased from progenitor cells to mature cells, while transcription factors such as PHIP gradually decreased. cytometry using anti-human-CD45-PE and anti-human-CD41a-FITC antibodies. We found that the multipotent to unipotent hierarchy in the human hematopoietic system is largely maintained in the xenograft experiment. Clustering Heatmap shows the distinct gene expression pattern of pro-neutrophil, pro-megakaryocyte, pro-T, pro-B and pro-Ery modules ( Figure 6A ). Examples of xenograft-stable progenitors were labeled in t-SNE map ( Figure 6B ). Figure 6C and Figure S6 ). Figure 6E ). These results suggest both CD71
Validation of the revised hematopoietic differentiation model
and CD114 are able to enrich lineage biased progenitors from MPP and lineage differentiation begins in early MPP stage. Thus, we provide functional evidence that the lineage primed progenitors in the adult human hematopoietic hierarchy are significantly biased for their lineage potential. We also identify a novel neutrophil differentiation pathway that is independent of classical myeloid progenitors.
Discussion
The method used in our study holds many advantages over other related technologies (Fan et al., 2015; Gierahn et al., 2017; Klein et al., 2015; Macosko et al., 2015; Yuan and Sims, 2016) . Microwell-seq demonstrates superiority in cost and convenience. A silicon wafer containing ~100,000 microwells cost $ 700, can be used to make hundreds of polydimethylsiloxane(PDMS) micropillar array, and a PDMS array can be used repeatedly to produce hundreds of agarose-made microwell array. The cost per experiment is no more than the cost of agarose, which is negligible. The magnetic propertiy of Our results provide strong supports for recently published single cell analysis work with mouse and human hematopoietic systems (Notta et al., 2016; Paul et al., 2015; Velten et al., 2017) . We observe an HSPC population that strongly resembles the "CLOUD-HSPC" proposed by Velten et al. (Velten et al., 2017) . We observed all the described early myeloid differentiation pathways proposed by Notta et al., Paul et al. and Velten et al. studies . However, our work differs from these studies in the following aspects. First, we did not use FACS to enrich specific progenitor types and ensured an unbiased and comprehensive analysis for all of the adult human hematopoietic stem and progenitor populations.
Secondly, the throughput of our analysis is higher than all of the published work by more than an order of magnitude; the processed cell number of the microwell-seq experiment is now close to normal FACS analysis. Thirdly, the comprehensiveness of our single cell atlas data resource for the human hematopoietic stem and progenitor cells allowed us to find many unknown clusters that are interesting for future studies. Finally, we validated an early neutrophil differentiation pathway that is previously uncharacterized.
We found that CD114 is found to be highly heterogeneous in adult human CD34 + cells. Moreover, CD114 antibody enriches neutrophil progenitors based on our single cell clonal forming assay and single cell qPCR assays.. Interestingly CD114 + pro-neutrophils can be found in both adult marrow and mobilized peripheral blood, but are absent in umbilical cord blood. Umbilical cord blood cells are becoming a prominent source of cells for HSC-based therapeutics due to the shortage of adult bone marrow HSCs and mobilized peripheral blood. However, it is well known that the time to neutrophil recovery, a major indicator of posttransplant mortality, is longer for cord blood than adult marrow (Brunstein and Wagner, 2006) . This phenomenon affects the efficacy of transplantation to some degree. The existence of neutrophil progenitor in adult HSPCs may be responsible for this phenomenon, which is worth for future investigation.
In conclusion, Microwell-seq opens a way for all laboratories around the world to harness the power of single-cell RNA-seq technology. We believe this easy to use system will gain its popularity and benefit the biomedical research community in the near future. In addition, the revised hematopoietic hierarchy model will provide guidance for the clinical implementation of HSCs transplantation and scientific research in hematology.
Tang, F., Barbacioru, C., Wang, Y., Nordman, E., Lee, C., Xu, N., Wang, X., Bodeau, J., Tuch, B.B., Siddiqui, A., et al. (2009 The fabrication of microarray. The microarray fabrication follows a strategy using a silicon microarray chip to make micropillar PDMS chip and then agarose microarray chip. Both silicon and PDMS chip are reusable, which greatly reduces cost and saves time.
See also Figure S1 and Table S1 . See also Figure S2 and Table S2 . See also Figure S2 , S3 and Table S3 . See also Figure S4 . See also Figure S5 . See also Figure S6 and Table S4 .
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Online method 3T3 and 293T preparation
293T and 3T3 cells were grown in DMEM (Corning, cat #10-013-CVR) with 10% FBS (Life Technologies, cat #10099141) and 1% penicillin-streptomycin (Life Technologies, cat #15140122).
Cells were washed twice by DPBS (Corning, cat #21-031-CVR), then treated with 0.25% trypsin (Invitrogen, cat #12604013) and quenched with growth medium. Cells were diluted by 1x DPBS (Corning, cat #21-031-CVR) with 2mM EDTA (Life Technologies, cat #15575020) and passed through a 40-micron cell strainer (Biologix, cat #151040). Cells were counted by hemocytometer and diluted to ~100,000/mL in 1x DPBS with 2mM EDTA.
Human CD34 + mobilized peripheral blood collection and process
Human mobilized peripheral blood samples were collected from donors at The First Affiliated Microwell-seq procedure:
Cell collection and lysis
Cell concentration should be carefully controlled in Microwell-seq. Both cell and bead concentrations were estimated by hemocytometer. The proper cell concentration is ~ 100,000 cells/mL(10% wells will be occupied by single cells). The proper beads concentration is ~ 1,000,000/mL(nearly every well will be occupied by single beads). Evenly distributed cell suspension were pipetted onto microwell array and extra cells were washed away. To eliminate cell doublets, the plate was inspected under a microscope. Cell doublets were removed by a capillary tube. Bead suspension was then loaded on the microwell plate which was placed on a magnet. Excess beads were washed away slowly. Cold lysis buffer (0.1 M Tris-HCl pH 7.5, 0.5 M LiCl, 1% LiSDS, 10 mM EDTA, and 5 mM dithiothreitol) was pipetted over the surface of the plate, and removed away after 10 min incubation. Then beads were collected and transferred to an RNase-free tube, washed twice with 1 mL 6X SSC, and once with 1ml of 1x RT buffer. Finally, beads were evenly distributed into five 1.5mL tubes, and every tube contains ~ 10,000 beads.
Reverse transcription
This step followed the instructions from Smart-seq2 protocol. 1 µL dNTP mix (10mM) was added to every tube and incubate in room temperature for 1 min. Then 9 µL RT mix was added. The RT mix contained 100U SuperScript II reverse transcriptase, 1x Superscript II first-strand buffer (Takara, cat #2690A), 10 U Rnase Inhibitor (Sangon, cat #B600008), 1M Betaine (Sigma, cat #B0300-1VL) and 6mM MgCl 2 (Ambion, cat #AM9539G). The beads were incubated at 42℃ for 90 minutes (shake beads every 15 min), followed by 72°C for 15 minutes to inactivate reverse transcriptase.
Exonuclease I treatment
After washing by 1X exonuclease I buffer, beads were suspended in 200 µL exonuclease I mix (containing 1x exonuclease I buffer and 1 U/µL exonuclease I (NEB, cat #B0293S)), and incubated at 37℃ for 45minutes to remove oligonucleotides which did not capture mRNA. Beads were pooled and washed once with 1 mL TE-SDS (1x TE + 0.5% Sodium Dodecyl Sulfate), once with 1 mL TE-TW (10 mM Tris pH 8.0, 1mM EDTA, 0.01% Tween) and once with 1 mL ultrapure distilled water (Life Technologies, cat #10977015).
cDNA amplification
Beads were then distributed to 5 tubes. Every tube was added with 25 µL PCR mix, which includes 1x A silicon wafer (~20 by 20 mm) containing ~10,000 microwells was used as a template.
Agarose (5%) microwell arrays were cast from the PDMS micropillars array before each experiment.
Polydimethylsiloxane (PDMS)was poured onto the silicon wafer(80 , 5h) to create micropillars arrays.
Load cell suspension
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